戻る
Clover Biopharmaceuticals, Ltd. (02197.HK)価格
02197.HK 株価推移チャート
CLOVER BIO-B (02197.HK)
Clover Biopharmaceuticals, Ltd.
HK$2.59
-1.14%
$-0.03
休場: Jan 16, 16:00:00 HKT
主要データ
前終値
$2.62
始値
$2.62
当日レンジ
$2.5 - $2.65
52週レンジ
$0.185 - $3.18
取引高
4.9M
平均取引高
10.9M
1株当たり利益(TTM)
-0.80
配当利回り
--
時価総額
$3.3B
CLOVER BIO-Bとは何ですか？
Clover Biopharmaceuticals Ltd. engages in the research and development of biopharmaceutical products. The company is headquartered in Shanghai, Shanghai and currently employs 243 full-time employees. The company went IPO on 2021-11-05. The Company’s products and candidates include Respiratory Syncytial Virus (RSV) Vaccine (SCB-1019), seasonal quadrivalent influenza vaccine AdimFlu-S, SCB-219M, COVID-19 Vaccine and others. The firm leverages the Trimer-Tag technology platform to conduct research and development (R&D) for innovative vaccines that can fulfill unmet need, with a focus on building a respiratory vaccine franchise and establishing a presence in the pediatric vaccine market. The Trimer-Tag is a product development platform for the creation of protein-based vaccines based on naturally trimerization-dependent targets. The firm conducts its business in the domestic and overseas markets.